Nevada’s marijuana regulators are working furiously to launch recreational sales on July 1, a fast-approaching deadline that could hinge on a court deciding whether the powerful liquor industry should be guaranteed a piece of the pot pie before tourists and residents can light up.
WeedMD Inc. (TSX-V:WMD) , a federally licensed producer of medical cannabis, is pleased to announce that on June 16, 2017, the Company received a supplemental license from Health Canada for the production of medical cannabis oils. The Company has imported a purpose-built high-throughput ethanol extraction machine from Germany, with the goal of starting R&D and production of cannabis oils immediately.
Canopy Growth Corporation ( TSX: WEED )), is pleased to provide the following significant summary of updates to inform shareholders and stakeholders of activities and developments across the global organization.
Gala Global, Inc. ( OTC:GLAG ), a publicly-traded development firm specializing in equity investments, debt financing and mergers and acquisitions in the biotechnology industry, has named Dr. Maqsood “Max” Rehman as the company’s Chief Operating Officer (COO).
The November 2016 passing of Proposition 64, the Adult Use of Marijuana act, brought legal recreational weed-use to California for the first time––making the Golden State one of only eight states to honor such a freedom. Here's what you need to know. (From Kindland)
An air of optimism is brewing around Canada's cannabis sector. In Alberta, a cannabis company is breaking ground this week on an 800 square-foot, state-of-the-art medical marijuana greenhouse near Edmonton. Then, another startup out of Okotoks will launch an online marketplace, called DooberExpress.com on Saturday. But is now the right time to buy into the hype and invest in this growing industry?
According to a research published by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016. The market is forecast to grow at a CAGR of 21.1% between 2017 and 2024, while culminating in 2024 global sales of $63.5 billion . The legal cannabis market is witnessing robust growth owing to the increasing legalization and decriminalization of marijuana across North America and Europe .
Today, Toronto -based mdBriefCase Group launched a unique online educational program, Medical Cannabis IQ: The Fundamentals , aimed at addressing the growing need for education among healthcare professionals around medical cannabis.
ChineseInvestors.com, Inc. (OTCQB: CIIX), which recently took part in SeeThruEquity’s 6th Annual Microcap Investor Conference in early June, offers educational consulting services for Chinese investors and is also pursuing opportunities in the cannabis market.
CFN Media Group ("CannabisFN"), announces the publication of an article discussing InMed Pharmaceuticals Inc. (CNSX: IN) (OTCQB: IMLFF) and the progress it is making in advancing its lead clinical trial candidate.
The cannabis market in the U.S. and worldwide continues to grow, but that doesn't mean everyone is open to the idea of legal marijuana. The banking industry is one example, as the Federal Deposit Insurance Corporation (FDIC) has generally been unsupportive of backing cannabis-related investments. This new digital currency could change that.
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada.
Harvest One Cannabis Inc. (TSXV:HVST) is very pleased to announce the appointment of Lisa Dea as Chief Financial Officer. Ms. Dea will be replacing Mr Kwong Choo as CFO, who will be assuming a new role as Vice President Finance for Harvest One.
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization.
According to a report by Arcview Market Research, the legal cannabis industry accelerated at a remarkable pace in 2016. North American consumers spent $6.7 billion on legal cannabis products, up 34% from 2015. The report forecasts that growth will reaccelerate in beginning of 2018, as adult use sales ramp up in Canada , California , and Massachusetts along with medical sales in Florida .
